• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Modern treatment of parkinsonism].

作者信息

Birkmayer W, Neumayer E

出版信息

Z Neurol. 1972;202(4):257-80.

PMID:4117647
Abstract
摘要

相似文献

1
[Modern treatment of parkinsonism].[帕金森病的现代治疗]
Z Neurol. 1972;202(4):257-80.
2
The balance of biogenic amines as condition for normal behaviour.生物胺平衡作为正常行为的条件。
J Neural Transm. 1972;33(2):163-78. doi: 10.1007/BF01260902.
3
Levodopa in Parkinsonism.
Drugs. 1971;2(4):257-61. doi: 10.2165/00003495-197102040-00001.
4
Dopaminergic supersensitivity in parkinsonism.
Adv Neurol. 1975;9:121-9.
5
[10 years of L-DOPA therapy of Parkinson's syndrome].帕金森综合征的左旋多巴治疗十年
Wien Klin Wochenschr. 1971 Apr 2;83(13):221-7.
6
[Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].
Arch Psychiatr Nervenkr (1970). 1973 Mar 19;217(1):95-112. doi: 10.1007/BF02552835.
7
Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor.单独使用左旋多巴或与脱羧酶抑制剂联合治疗的帕金森病患者脑脊液中的酸性单胺代谢产物。
Eur Neurol. 1973;9(6):349-62. doi: 10.1159/000114243.
8
Levodopa and amantadine in the treatment of Parkinsonism.左旋多巴与金刚烷胺治疗帕金森病
Practitioner. 1972 Apr;208(246):499-504.
9
Ro 4-4602 and levodopa in the treatment of Parkinsonism.
Neurology. 1974 May;24(5):482-6. doi: 10.1212/wnl.24.5.482.
10
Methyldopahydrazine as an adjunct to L-dopa therapy in parkinsonism.甲基多巴肼作为左旋多巴治疗帕金森病的辅助药物。
Neurology. 1972 Apr;22(4):384-92. doi: 10.1212/wnl.22.4.384.

引用本文的文献

1
Levodopa treatment: impacts and mechanisms throughout Parkinson's disease progression.左旋多巴治疗：贯穿帕金森病进展过程中的影响及机制。
J Neural Transm (Vienna). 2025 Apr 11. doi: 10.1007/s00702-025-02893-4.
2
Monoamine reuptake inhibitors in Parkinson's disease.单胺再摄取抑制剂在帕金森病中的应用。
Parkinsons Dis. 2015;2015:609428. doi: 10.1155/2015/609428. Epub 2015 Feb 25.
3
Is NADH effective in the treatment of Parkinson's disease?烟酰胺腺嘌呤二核苷酸（NADH）对帕金森病的治疗有效吗？

本文引用的文献

1
L-dopa: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice.L-多巴：对小鼠脑内多巴胺、去甲肾上腺素和 5-羟色胺浓度的影响。
Science. 1970 May 15;168(3933):849-50. doi: 10.1126/science.168.3933.849.
2
[Delirious states in post-encephalitic parkinsonism].[脑炎后帕金森综合征中的谵妄状态]
Rass Neuropsichiatr. 1951 Jan-Feb;5(1):22-44.
3
BLOCKADE OF ENDOGENOUS NOREPINEPHRINE SYNTHESIS BY ALPHA-METHYL-TYROSINE, AN INHIBITOR OF TYROSINE HYDROXYLASE.酪氨酸羟化酶抑制剂α-甲基酪氨酸对内源性去甲肾上腺素合成的阻断作用
Drugs Aging. 1998 Oct;13(4):263-8. doi: 10.2165/00002512-199813040-00002.
4
Assessment of extrapyramidal disorders.锥体外系疾病的评估。
Br J Clin Pharmacol. 1981 Feb;11(2):129-51. doi: 10.1111/j.1365-2125.1981.tb01118.x.
5
DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness.帕金森病中的DL-3,4-苏式二羟基苯丝氨酸：对体位性低血压和头晕的影响
J Neural Transm. 1983;58(3-4):305-13. doi: 10.1007/BF01252816.
6
Nucleus ruber and L-dopa psychosis: biochemical post-mortem findings.红核与左旋多巴所致精神病：尸检生化结果
J Neural Transm. 1974;35(2):93-116. doi: 10.1007/BF01250738.
7
Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study.
J Neural Transm. 1985;64(2):113-27. doi: 10.1007/BF01245973.
8
Iron, a new aid in the treatment of Parkinson patients.
J Neural Transm. 1986;67(3-4):287-92. doi: 10.1007/BF01243354.
9
Impairment of motor planning in patients with Parkinson's disease: evidence from ideomotor apraxia testing.帕金森病患者运动计划障碍：来自观念运动性失用症测试的证据。
J Neurol Neurosurg Psychiatry. 1986 Nov;49(11):1266-72. doi: 10.1136/jnnp.49.11.1266.
10
Hallucinations in Parkinson disease: neuropsychological study.帕金森病中的幻觉：神经心理学研究
Ital J Neurol Sci. 1990 Aug;11(4):373-9. doi: 10.1007/BF02335940.
J Pharmacol Exp Ther. 1965 Jan;147:86-95.
4
[NEW MEANS OF CONTROLLING EXTRAPYRAMIDAL MOTOR DISORDERS].
Arzneimittelforschung. 1964 Jun;14:SUPPL:599-601.
5
[THE EFFICACY OF L-DOPA IN PARKINSON PATIENTS WITH AND WITHOUT STEREOTACTIC BRAIN SURGERY].[左旋多巴在接受和未接受立体定向脑手术的帕金森病患者中的疗效]
Arch Psychiatr Nervenkr. 1964 Jun 1;205:281-92. doi: 10.1007/BF00395715.
6
[HEAT REGULATION IN POSTENCEPHALITIC PARKINSONISM].[脑炎后帕金森综合征中的体温调节]
Nervenarzt. 1963 Aug;34:373-4.
7
[The L-dihydroxyphenylalanine (L-DOPA) effect in Parkinson's syndrome in man: On the pathogenesis and treatment of Parkinson akinesis].[左旋多巴（L-DOPA）对人类帕金森综合征的作用：关于帕金森氏运动不能的发病机制及治疗]
Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr. 1962;203:560-74. doi: 10.1007/BF00343235.
8
[Features of medical therapy of Parkinson's syndrome].[帕金森综合征的药物治疗特点]
Wien Klin Wochenschr. 1962 Oct 12;74:700-2.
9
[On the effects of I-DOPA on motor disorders in Parkinson's syndrome. An electromyographic study].[关于左旋多巴对帕金森综合征运动障碍的影响。一项肌电图研究]
Wien Z Nervenheilkd Grenzgeb. 1962;20:90-100.
10
[The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].[左旋多巴（L-3,4-二羟基苯丙氨酸）对帕金森氏症运动不能的作用]
Wien Klin Wochenschr. 1961 Nov 10;73:787-8.